Rapid CK-MB Test

Creatine Kinase-MB (CK-MB) Rapid Test Device (Whole Blood/Serum/Plasma)

Name: Creatine Kinase-MB (CK-MB) Rapid Test Device (Whole Blood/Serum/Plasma)
Brand: reOpenTest
SKU: CRD-CKMB
Availability: InStock

Fast detection of Creatine Kinase-MB in whole blood, serum, or plasma.

CE Certified

ISO 13485

Request Quote View Specs

Main image of Creatine Kinase-MB (CK-MB) Rapid Test Device (Whole Blood/Serum/Plasma)

Why Choose reOpenTest Cardiology Kits?

Our tests are engineered for accuracy, reliability, and ease of use, ensuring confidence in every result.

Early AMI Detection

Aids in the early detection of acute myocardial infarction (AMI) through CK-MB measurement.

Rapid Results

Provides results within minutes for rapid clinical intervention.

Versatile Sample Types

Suitable for use with whole blood, serum, or plasma samples.

Product Overview

The CK-MB Rapid Test Device is a point-of-care immunochromatographic assay for the qualitative detection of Creatine Kinase-MB in whole blood, serum, or plasma. It serves as an aid in the diagnosis of myocardial injury.

Technical Specifications

Detection Target	Creatine Kinase-MB (CK-MB)
Sample Type	Whole Blood, Serum, Plasma
Methodology	Immunochromatography
Detection Range	Positive/Negative (Qualitative)
Reaction Time	10-15 minutes
Storage Conditions	2-30u00b0C
Shelf Life	18 months

Procedure & Interpretation

Step-by-Step Procedure

Add 3 drops of sample to the test well.
Wait 10-15 minutes.
Read the results. Do not interpret after 15 minutes.

Result Interpretation

Positive: A visible band in the test region (T) and the control region (C) indicates a positive result.

Negative: A visible band only in the control region (C) indicates a negative result.

Invalid: If no band appears in the control region (C), the test is invalid and should be repeated with a new device.

Frequently Asked Questions

CK-MB levels typically rise within 3-6 hours after the onset of chest pain, peaking at 12-24 hours.

Besides AMI, CK-MB can be elevated in myocarditis, cardiac trauma, and certain muscular dystrophies.

CK-MB is less specific than Troponin I or T, therefore Troponin is prefered for diagnosis of AMI. However, CK-MB is still used as an aid in diagnosis.

Technical Documents

Download product inserts and brochures for detailed information.

No technical documents are available at this time. Please check back soon.

Creatine Kinase-MB (CK-MB) Rapid Test Device (Whole Blood/Serum/Plasma)